top of page

SUBSCRIBE TO OUR NEWSLETTER

THE LATEST NEWS IN CANCER CLINICAL RESEARCH

AT MEDSIR WE ARE DEDICATED TO OFFER THE MOST RELEVANT NEWS ON THE LATEST ADVANCEMENTS IN ONCOLOGY CLINICAL RESEARCH. FIND OUT THE LATEST NEWS ON ONCOLOGY RESEARCH, REGULATORY APPROVALS, EVENTS, SCIENTIFIC CONFERENCES AND MUCH MORE!

DOWNLOAD COMPANY DOSSIER

Search

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Dec 12, 20247 min read

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

107 views

MEDSIR showcases the DEMETHER Study: advancing therapeutic de-escalation and more effective treatments for advanced breast cancer

Dec 5, 20245 min read

MEDSIR showcases the DEMETHER Study: advancing therapeutic de-escalation and more effective treatments for advanced breast cancer

115 views

MEDSIR takes part in the Nexus Conference to address the challenges and opportunities of geographic diversity in clinical trials

Oct 23, 20244 min read

MEDSIR takes part in the Nexus Conference to address the challenges and opportunities of geographic diversity in clinical trials

89 views

Brain metastases: an oncological challenge requiring innovative solutions and multidisciplinary approaches

Sep 20, 20244 min read

Brain metastases: an oncological challenge requiring innovative solutions and multidisciplinary approaches

124 views

MEDSIR presents new studies at ESMO that advance treatment of patients with poor prognosis cancers

Sep 16, 20245 min read

MEDSIR presents new studies at ESMO that advance treatment of patients with poor prognosis cancers

150 views

Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer

Sep 12, 20246 min read

Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer

38 views

MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer

Jun 3, 20244 min read

MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer

181 views

MEDSIR, Debiopharm, initiate clinical collaboration to explore potential synergy of Debio 0123 & Sacituzumab Govitecan in advanced breast cancer

May 28, 20244 min read

MEDSIR, Debiopharm, initiate clinical collaboration to explore potential synergy of Debio 0123 & Sacituzumab Govitecan in advanced breast cancer

281 views

MEDSIR Presents Two Translational Studies Focused on Biomarkers at AACR2024 Annual Meeting

Apr 8, 20243 min read

MEDSIR Presents Two Translational Studies Focused on Biomarkers at AACR2024 Annual Meeting

45 views

The Lancet publishes positive results from the PHERGain study in patients with localized HER2-positive breast cancer

Apr 4, 20243 min read

The Lancet publishes positive results from the PHERGain study in patients with localized HER2-positive breast cancer

185 views

Press Release: DEBBRAH Cohort 5 and ATRACTIB trial at San Antonio Breast Cancer Symposium

Dec 8, 20235 min read

Press Release: DEBBRAH Cohort 5 and ATRACTIB trial at San Antonio Breast Cancer Symposium

307 views

Press Release: PARSIFAL-LONG at San Antonio Breast Cancer Symposium

Dec 7, 20234 min read

Press Release: PARSIFAL-LONG at San Antonio Breast Cancer Symposium

542 views

Press Release: MiRaDor at San Antonio Breast Cancer Symposium

Dec 7, 20234 min read

Press Release: MiRaDor at San Antonio Breast Cancer Symposium

139 views

MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer

Oct 31, 20237 min read

MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer

126 views

Phergain Collaborators’ Ecosystem in Spain.

Jul 20, 20236 min read

Phergain Collaborators’ Ecosystem in Spain.

99 views

MEDSIR at ASCO 2023

Jun 13, 202323 min read

MEDSIR at ASCO 2023

218 views

PALMIRA Study at ASCO 2023

Jun 5, 20232 min read

PALMIRA Study at ASCO 2023

149 views

PHERGain study at ASCO 2023

Jun 3, 20232 min read

PHERGain study at ASCO 2023

152 views

Gema Llorente, new corporate CFO of MEDSIR

Jan 26, 20231 min read

Gema Llorente, new corporate CFO of MEDSIR

79 views

Rosario Rodríguez, New Chief Trial Officer at MEDSIR

Dec 13, 20221 min read

Rosario Rodríguez, New Chief Trial Officer at MEDSIR

64 views

bottom of page